GlassScriptPhysician profile
Christopher Thomas Rose
NPI 1548550502
$9,752.71
in general payments reported to CMS, 2019-2025
57 companies · $755 in 2025
The $755 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $174 · 2021: $846 · 2022: $2,490 · 2023: $3,013 · 2024: $2,232 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,316 · Consulting Fee: $1,603 · Education: $80.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,315.99 |
| Consulting Fee | $1,603.00 |
| Education | $80.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,468.00 | 2024 | |
| Abbvie INC. | $1,208.11 | 2021-2025 | Vraylar, Ubrelvy, Qulipta |
| Otsuka America Pharmaceutical, INC. | $606.45 | 2021-2024 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Aerin Medical INC. | $512.01 | 2019-2024 | |
| Pfizer INC. | $373.11 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $341.49 | 2022-2023 | |
| Astrazeneca Pharmaceuticals LP | $338.41 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $324.94 | 2022-2024 | Caplyta |
| Corium, LLC | $279.68 | 2022-2024 | Azstarys |
| Vanda Pharmaceuticals INC. | $278.72 | 2020-2023 | Hetlioz, Fanapt |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $277.50 | 2021-2025 | Xifaxan, Trulance |
| Jazz Pharmaceuticals INC. | $258.08 | 2021-2025 | |
| Amgen INC. | $252.07 | 2020-2023 | Repatha, Otezla |
| Medtronic, INC. | $236.51 | 2022-2025 | Straightshot, Propel, Merocel |
| Janssen Pharmaceuticals, INC | $214.74 | 2021-2023 | Spravato, Xarelto |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $212.62 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $209.09 | 2021-2023 | Belsomra, Steglatro, Steglujan |
| Lilly USA, LLC | $194.99 | 2021-2024 | Mounjaro |
| Idorsia Pharmaceuticals US INC | $185.49 | 2022-2023 | Quviviq |
| Intersect Ent, INC. | $184.60 | 2019 | |
| Novo Nordisk INC | $177.81 | 2020-2024 | Rybelsus, Ozempic, Wegovy |
| Smith+Nephew, INC. | $168.36 | 2025 | Halo, Tula, Ent Sinus |
| Glaxosmithkline, LLC. | $158.12 | 2023-2025 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $156.51 | 2021-2024 | Trintellix |
| Kowa Pharmaceuticals America, INC. | $113.05 | 2021-2024 | Livalo, Seglentis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.41 | 2021-2023 | |
| Collegium Pharmaceutical, INC. | $79.57 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $64.59 | 2021-2023 | Austedo |
| Sanofi-Aventis U.S. LLC | $54.95 | 2024 | |
| Halozyme INC | $53.28 | 2023 | |
| Livanova USA, INC. | $48.63 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Genzyme Corporation | $46.62 | 2024 | |
| Scilex Pharmaceuticals INC. | $40.27 | 2023-2024 | Ztlido |
| Nevro Corp. | $40.06 | 2022 | |
| Melinta Therapeutics, LLC | $33.32 | 2025 | Orbactiv, Kimyrsa, Rezzayo |
| Hologic Sales and Service, LLC | $31.76 | 2024 | Coolseal Generator |
| Biodelivery Sciences International, INC. | $30.52 | 2021 | |
| Eisai INC. | $30.17 | 2020-2021 | |
| Amarin Pharma, INC. | $30.07 | 2021 | |
| Horizon Therapeutics Plc | $29.59 | 2022 | |
| Ascendis Pharma Endocrinology INC | $29.19 | 2025 | Yorvipath |
| Upsher-Smith Laboratories LLC | $24.97 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $23.96 | 2025 | |
| Astellas Pharma US INC | $23.36 | 2024 | Veozah |
| Scynexis, INC. | $19.56 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.11 | 2025 | Dupixent |
| Ibsa Pharma INC. | $18.68 | 2023 | Tirosint, Licart |
| Abbott Laboratories | $18.57 | 2022 | |
| Redhill Biopharma INC. | $18.31 | 2021 | |
| Agile Therapeutics, INC. | $16.67 | 2023 | Twirla |
| Exact Sciences Corporation | $15.90 | 2025 | The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $15.56 | 2023 | Gemtesa |
| Avanir Pharmaceuticals, INC. | $15.48 | 2022 | |
| Bausch Health US, LLC | $13.87 | 2022 | |
| Boston Scientific Corporation | $13.74 | 2023 | |
| Nabriva Therapeutics, Plc | $13.37 | 2022 | |
| Esperion Therapeutics, INC. | $12.14 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.